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Abstract
Mycobacterium tuberculosis (Mtb) causes tuberculosis, one of the leading causes of fatal
infectious diseases worldwide. Cell-cell recognition between the pathogen Mtb and its host are
mediated in part by glycosylated proteins. So far, glycoproteins in Mtb are understudied and for
only very few glycoproteins glycosylation sites have been described, e.g., alanine and proline rich
secreted protein apa, superoxide dismutase SODC, lipoprotein lpqH and MPB83/MPT83. In this
study, glycosylated proteins in Mtb culture filtrate were investigated using liquid chromatography-
mass spectrometry approaches and bioinformatic analyses. To validate the presence of
glycoproteins, several strategies were pursued including collision induced dissociation, high
energy collision dissociation and electron transfer dissociation techniques, and bioinformatics
analyses involving a neutral loss search for glycosylated moieties. After extensive data curation,
we report glycosylation sites for thirteen Mtb glycoproteins using a combination of mass
spectrometry techniques on a dataset collected from culture filtrate proteins. This is the first
glycoproteomics study identifying glycosylation sites on mycobacterial culture filtrate proteins
(CFP) on a global scale.
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1. Introduction
Worldwide, tuberculosis has one of the highest mortalities of any infectious diseases and
thus continues to be a major public health threat[1]. The causative agent, Mycobacterium
tuberculosis (Mtb), has a complex relationship with its host that is mediated in part by
secreted, glycosylated proteins. For instance, it has been proposed that mannose receptors on
host cells might directly interact with mannosylated Mtb proteins to enter the macrophages
for survival [2]. While it is now no longer questioned that bacteria including mycobacteria
produce glycoproteins [3], our current knowledge about the glycoproteins of Mtb is very
limited. In fact, since the first indication that Mtb is reactive towards ConA lectins in 1989
[4], glycosylation sites for only four Mtb glycoproteins have so far been described. Mass
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spectrometric analysis of purified alanine and proline rich secreted protein APA, digested
with subtilisin, identified Thr49, Thr57, Thr66 and Thr316 as mannosylated sites [5, 6]. It
was also found that changes in the mannosylation pattern led to a reduced stimulatory T-
lymphocyte response, pointing to the biological importance of the sugar moiety [7]. A
combination of chymotrypsin and trypsin digestion was necessary to determine the
glycosylation sites in overexpressed superoxide dismutase SodC [8] by mass spectrometry,
indicating a N-terminal clustering of Ser and Thr mannosylation sites at Thr45, Thr46,
Ser48, Thr51, Ser53, and Ser56. Both APA and SodC had sites containing multiple mannose
residues such as mannobiose, mannotriose etc., SodC with up to 9 mannose residues [5, 6,
8]. For the characterization of the lipoprotein LpqH site-directed mutagenesis of several Thr
residues (Thr34, Thr35, Thr36, Thr40, and Thr41) was used in combination with loss of
ConA binding [9] . The M. bovis cell surface lipoprotein MPB83 was found to be
mannosylated by mass spectrometry [10]. Detailed MS analysis showed a combination of
mono-, di- and tri-mannosylations at Thr48 and Thr49. The protein sequence of the MPT83
is identical to the bovine MPB83, suggesting that the same Thr residues are modified in Mtb.
When using a recombinant expression system together with ConA binding to determine
sequence patterns in O-glycosylation sites, Herrmann et al. identified eight glycoproteins
including apa, SodC, LpqH, MPT83, and lipoproteins LppN, LppQ, phosphate-binding
protein PstS1, and amino acid ABC transporter/probable glutamine-binding lipoprotein
GlnH [11]. Expression and ConA binding analysis of the predicted glycosylation sites
indicated that O-glycosylation sites are rich in Pro, Gly and Ala [11]. Recent proteomics
approaches have identified additional glycoprotein candidates, but so far, little progress has
been made in characterizing glycosylation sites in new glycoproteins [2, 12–14] .
To identify potentially glycosylated proteins in Mtb secreted proteome, we investigated the
culture filtrate proteins of Mtb using liquid chromatography-mass spectrometry approaches
and bioinformatic analyses. Overall, we report glycosylation sites for thirteen Mtb
glycoproteins using a combination of mass spectrometry techniques on a dataset of 900,000
spectra collected from CFP. To validate the presence of glycoproteins, several strategies
were pursued including collision induced dissociation (CID), high energy collision
dissociation (HCD) and electron transfer dissociation (ETD) techniques, and bioinformatics
analyses involving a neutral loss search for glycosylated moieties. Taken together, this is the
first glycoproteomics study identifying glycosylation sites on mycobacterial CFP proteins on
a global scale. The number of verified Mtb glycoproteins has been tripled in this study.
2. Material and methods
Chemicals and reagents
Acetonitrile and water, (Chromasolv LC-MS quality), formic acid (99%), methyl α-D-
mannopyranoside, 1-ethyl-3 (3-dimethylaminopropyl) carbodiimide, glycine, dithiothreitol
(DTT), iodoacetamide, Tris(2-carboxyethyl)phosphine hydrochloride (TCEP), and urea
were supplied by Sigma-Aldrich, St. Louis, MO. Calcium chloride, manganese chloride, and
sodium chloride were from Mallinckrodt, Hazelwood, MO, TRIS-HCl was from MP
Biomedicals, Santa Ana, CA. Lysyl endopeptidase (Lys-C) Wako USA Richmond, Va.
Trypsin (modified sequencing grade) was from Promega, Madison, WI. All other chemicals
and reagents were of the highest purity available. CFP (05.CS.93.1.12.5.CFP) was obtained
from the Biodefense and Emerging Infections Research Resources Repository (Manassas,
VA).
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Proteolytic digestion
Protein samples were proteolytically digested in solution as follows: lyophilized protein
samples (10–20 µg) were resolubilized in 40 µL of freshly prepared 8 M urea, 100 mM
TRIS•HCl, pH 8.5 and reduced by incubation with a final concentration of 3 mM TCEP in
LC-MS water for 20 min at RT. Reduced cysteines were alkylated by addition of 10 mM
iodoacetamide and incubated for 15 min at RT in the dark. Proteolysis was initiated with 0.1
µg Lysyl endopeptidase (Lys-C) and allowed to proceed for 3 hours at room temperature in
the dark. The sample was diluted to a final concentration of 2 M urea by the addition of 100
mM TRIS•HCl, pH 8.5 and adjusted to 1 mM CaCl2. Next, trypsin (0.5 µg, sequencing
grade) was added to the mixture and incubated overnight (ca. 18 h) at room temperature in
the dark. The digestion was quenched by the addition of formic acid to a final concentration
of 5%. The digested peptides were desalted and concentrated into one fraction with a C8
peptide macrotrap (Bruker-Michrom Bioresources, Auburn CA) on an Alliance 2795
(Waters, Milford MA). The collected material was lyophilized and resuspended in 0.2%
formic acid (Sigma, St. Louis MO).
Lectin coupled magnetic beads
Concanavalin A (ConA; EY Laboratories, San Mateo, CA) was dissolved in coupling buffer
(10 mM potassium phosphate, 150 mM sodium chloride, pH 5.5). Magnetic beads (Bioclone
San Diego, CA) with both a carboxy-terminated and amine-terminated functionality was
used. ConA was bound to the magnetic beads with the addition of 1-ethyl-3 (3-
dimethylaminopropyl) carbodiimide and reacted at room temperature on a rotisserie for 24
hours at a pH of 4.5 – 6.0. The beads were washed three times with wash/storage buffer (10
mM TRIS-HCl pH 7.5, 500 mM NaCl, 0.1% BSA (w/v), 1 mM EDTA, 0.1% NaN3) and
blocked with 1 M Glycine, pH 8 for 2 hours and washed again three times.
Lectin Affinity Purification
Lyophilized peptides were resuspended in lectin loading buffer (20 mM TRIS-HCl pH 7.4,
150 mM NaCl, 1 mM MnCl2, 1 mM CaCl2) and rotated for 2 hours at room temperature,
washed 3 times, and eluted with the 200 mM methyl α-D-mannopyranoside.
LC-MS
LC-MS analysis was performed on a nanoLC coupled to an Orbitrap, Orbitrap Elite or
LQTFT (Thermo Fisher Scientific, Waltham, MA). The LC gradient was 2–30% buffer B
(80% ACN, 0.2% formic acid) on a 75 µm ID silica capillary column packed in house with
15 cm of C18AQ, 3 µm, 120 Å (Dr. Maisch, Ammerbuch-Entringen, Germany) in 160 min
analysis. The mass spectrometer was operated in different data dependent modes with the
scan event 1 performed in the Orbitrap with an Automated Gain Control (AGC) injection
target of 1e6 and a maximum injection time of 200 milliseconds (ms) for the full scan. The
following dependent scan setups were used: 1) 20 dependent scans in the IT; rapid scan
mode; IT AGC target was 5,000 ions with a maximum injection time of 50 ms; 2) data
dependent NL MS3; 3 dependent scans on NL of hexose using CID with 50K resolution in
the FT; FT AGC target was 5e5 ions; 3) 20 dependent scans using HCD with 15K resolution
in the Orbitrap; FT AGC target was 1e6 ions with a maximum injection time of 200 ms; 4)
10 dependent scans using ETD; FT AGC target was 1e6 ions with a maximum injection time
of 200 ms; ETD reagent AGC target was 2e5 ions with a maximum injection time of 200 ms
and an activation time of 100 ms with supplemental activation enabled.
Ions from m/z = 400 to 1600 were surveyed. Charge state screening and rejection were
enabled so that charge states of the precursor ion ≥ +2 were accepted. Injection waveforms
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were enabled. Dynamic exclusion was also enabled for the maximum list size of 500 for a
duration of 90 seconds. At least three technical replicates were run for each sample.
Data analysis
Raw data were analyzed with MaxQuant (version 1.3.0.5)[15–17] against a Mycobacterium
tuberculosis database (downloaded from Uniprot on Nov28th, 2012 containing 3977 Mtb
sequences) and a contaminant database (247 entries). A decoy database was constructed by
MaxQuant on-the-fly to determine the false discovery rate (FDR). Trypsin ([KR][^P]) was
specified as the proteolytic enzyme with up to two missed cleavages. Carboxyamidomethyl
modification of cysteine (57.0215 Da) was specified as a fixed modification. Variable
modifications included mono (162.0528 Da), di (324.1056 Da), and tri (486.1584 Da)
hexose additions on serine and threonine (neutral losses of the hexoses were also specified),
oxidation of methionine (15.9949 Da), and protein N-terminus acetylations (42.0106 Da).
Peptides were searched with a tolerance of 6 ppm after MS1 recalibration in MaxQuant and
an MS/MS tolerance of 0.5 Da (ion trap) and 30 ppm (FT) and a peptide and protein FDR of
1%. Weblogo was used to create a weblogo [18]. The unique sequences of all peptides
containing Oglycosylation sites were submitted to WebLogo and the resulting sequence atlas
was shown.
3. Results
The aim of this study was to identify glycosylation sites in Mtb CFP using nanoLC coupled
tandem mass spectrometry. Our rationale was that mass spectrometers have significantly
advanced since the first investigations in the nineties that glycosylation site identification
directly from CFP seemed feasible. Since mannosylations have previously been described in
Mtb, [2, 5–8, 10, 13, 14] we focused on simple hexose modifications such as mannosylations
in this analysis. For the comprehensive analysis of hexosylated glycoproteins in CFP, we
pursued the strategy outlined in Figure 1. CFP samples were analyzed by CID, NL MS3,
HCD and ETD. ETD spectra were generated from CFP and ConA enriched CFP samples.
Collected spectra were analyzed by MaxQuant with a peptide and protein FDR ≤ 1%.
While the MaxQuant analysis is generally very powerful, we found it was essential that
additional manual curation is performed to assure correct site identification. This stringent
curation resulted in 34 glycosylation site identifications of 13 glycoproteins. Table 1
summarizes the highest confidence glycosylation site identifications along with the
technique that provided the highest score and lowest posterior error probability. Please note
that in many cases multiple spectra support the identification and site localization.
3.1. Identified Glycoproteins
As shown in Table 1, glycosylation sites were identified for 13 glycoproteins. We could
confirm the T316 glycosylation site of alanine and proline-rich secreted protein apa and
additionally found one, two or three hexoses between Thr313, Thr315, Thr316 and T318 as
glycosylation sites.
In addition, we identified glycosylation sites for the following proteins that have been
identified in a recent screen using ConA [14]: the putative uncharacterized protein MT3595
(Rv3491; O06354), possible glycosyl hydrolase MT1128 (Rv1096; O53444), beta-lactamase
blaA (Rv2068; P0C5C1), probable membrane protein MT2867.1 (Rv2799; P71652),
putative lipoprotein LprA (Rv1270c; Q11049), and gamma-glutamyltransferase (Rv2391;
P71750). On top of that, we identified glycosylation sites of six more glycoproteins listed in
Table 1 in the culture filtrate. Interestingly, three of the glycoproteins are predicted
lipoproteins (betalactamase, LprA, LppO).
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With the exception of apa, most proteins identified as glycoproteins in this study have not
been characterized. However, some functions can be annotated. For instance, the enzyme
betalactamase mediates resistance to penicillin and other beta-lactam antibiotics by cleaving
their beta-lactam ring [19]. The possible glycosyl hydrolase is also known as putative
polysaccharide deacetylase. Because of its ability to deacetylate N-acetylglucosamine
(GlcNAc) residues of the host, it may be viewed as a potential virulence factor [20].
Furthermore, deacetylases have been suggested to promote the evasion of the immune
responses of the host through their ability to deacetylate GlcNAc residues [20].
3.2. CID spectra, including NL MS3
A common feature of the CID spectra is the occurrence of a neutral loss of the hexose
(162.0528) from the precursor. In cases where only one potential glycosylation site is
present in the peptide, the glycosylation site can still be assigned. As shown in Figure 2,
assignment of the glycosylation site is also possible when the hexose fragmentation
competes with the backbone fragmentation and two ion series exist for the glycosylated and
deglycosylated peptide as is the case for the hexosylated LNLPDIPLQIPTPR peptide (aa
362–375) of the uncharacterized membrane protein Rv3835. The doubly charged precursor
ion m/z = 866.0099 results in a mass of 1730.0053 Da, one hexose (162.0528 Da) higher
than the molecular weight of the peptide, indicating one hexose being attached. Fragment
ions that support the assignment of the hexosylated Thr373 are y4+Hex, y5+Hex, y7+Hex,
y8+Hex, y10+Hex, y11+Hex and b12+Hex. The ion corresponding to y6+Hex was also seen
at low abundance, but was not assigned since it has almost identical mass to the unmodified
b5 ion (535.2722 vs. 535.3239).
Neutral loss (NL)-dependent MS3 experiments have been successfully used in
phosphorylation analysis [21]. As seen in the CID spectra, neutral losses can also occur in
glycosylated peptides. Therefore, we conducted NL-triggered MS3 experiments for the
characterization of glycosylation site identification. Shown in Figure 3 is the spectrum for
the tryptic peptide TPATVPSSR (aa 47–56) of gamma-glutamyltransferase Rv2394. MS3
was performed on the NL of doubly charged m/z 993.43, indicating a total of 6 hexoses
attached to the peptide. A series of singly and doubly charged neutral losses dominates the
spectrum. The y3 ion was identified with three and four hexoses. This indicates that at least
four hexoses are present at Ser54 and/or Ser55. It cannot be stated with absolute certainty
whether one of the Ser is modified with four sugars or both are modified with one and three
or two and two hexoses (or whether in fact a combination of these sugar modifications are
present in this peptide). The b62++2Hex ion supports the presence of two hexoses at either
Thr47 or Thr51. The presence of the unmodified b4 ion supports the interpretation that
Thr51 is more likely modified with two hexoses, but the modification of Thr47 cannot be
excluded at this point, because we cannot exclude that the sugar might have been
fragmented before the backbone.
3.3. HCD spectra
In contrast to CID spectra, HCD spectra provide high accuracy for the precursor and the
fragment ions, which aids disambiguation in peptide identification and modification site
localization when the sugar has not been lost. Figure 4 shows the MS/MS spectrum of the
singly hexose modified QPFSLQLIGPPPS*PVQR peptide (aa164–180) of the putative
uncharacterized protein MT3595 (O06354). As can be seen in Figure 4, the y-ion series
y8+Hex, y9+Hex, y10+Hex, y11+Hex, y12+Hex, y13+Hex unambiguously support the
localization of the hexose at Ser176. A similar ion series can also be seen for the unmodified
peptide, indicating that the dissociation of the sugar competes with backbone fragmentation.
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Previous investigations of glycosylation sites on GlcNAc-modified peptides revealed typical
oxonium ions at m/z = 204.086 (and subsequent species exhibiting additional water losses)
in the HCD spectra [22],[23]. The analog oxonium ion of a hexose such as mannose has an
m/z = 163.0606. We therefore screened all HCD spectra but did not detect any oxonium ions
at m/z = 163.0606. Similar observations were made by Darula et al. [24]. A possible
explanation for this difference is that the oxonium ions formed from a hexose lack a nitrogen
in contrast to their analog GlcNAc oxonium ions, and thus are less stable.
While powerful, HCD is not always able to provide a final glycosylation assignment. An
illustrative example where a final conclusion can currently not be drawn is the peptide
SPIVATTDPSPFDPC(57)R (aa 68–83) of the probable membrane protein Rv2799. The
doubly charged precursor ion has an m/z = 1042.97, clearly indicating that two hexoses are
added to the carbamidomethylated peptide. The b- and y-ion series also support the
identification of the peptide with high accuracy. However, difficulties arise when trying to
unambiguously assign the glycosylation site(s). Possible assignments are either a single
hexose on two sites or two hexoses at one site. This leads to many possible theoretical
fragments that are identical for all considered possibilities. In addition, at present, we cannot
exclude that a dihexose would result in one neutral loss and the second hexose may remain
on the peptide chain. There is also a possibility that multiple isomers are present resulting in
overlaying fragmentation patterns. Several best matching scenarios are shown in Table 1.
One HCD spectrum supports the localization of the glycosylation at Ser68 and Thr73,
another HCD spectrum supports the localization of the glycosylation at Thr74 and Thr77.
The most plausible explanation is that multiple glycosylation patterns exist.
3.4. ETD spectra
As a non-ergodic dissociation technique, electron transfer dissociation is generally regarded
as the best choice for PTM localization [25]. We therefore also explored this fragmentation
technique for the characterization of glycosylations in CFP. Of note, all ETD spectra that
were assigned as best identification were from ConA enriched samples, indicating that an
enrichment may further improve glycosylation site identification.
Figure 5 displays the ETD spectrum of the triply charged m/z 750.3648 of
DIPASEIPPLPNT*S*S*PK (aa 254–270) of possible glycosyl hydrolase (O53444). Z3 ion
with 1 Hex modification, z4 with 2 Hex modifications and z5 with 3 Hex modifications
indicates that Thr 266, Ser267 and S268 are modified with one hexose each. This is further
supported by c13 ion with 1 Hex and c14 ion with 2 Hex modifications. ETD thus allowed
the characterization of three modified amino acids in one spectrum.
There are also examples in Table 1, where a definite assignment cannot be made using ETD.
For instance, the GEALPAGGTTATPR peptide of the 35kDa protein Rv2744c was
modified with a single Hex modification at Thr248, Thr249 or Thr251. An explanation for
this ambiguity is the possibility that isomeric forms coexisted.
3.5. Glycosylation site motif
After extensive analysis of the mass spectra, we determined the amino acid composition of
the glycosylation motifs of the high confidence identifications by submitting the unique
sequences of all peptides containing a glycosylation site to WebLogo [18]. Figure 6 shows
the resulting sequence logo, where the height of each amino acid indicates its relative
frequency at this position. Roughly 60% showed the glycosylation site at the Thr residue and
40% at the Ser. The sequence logo also reveals a higher probability for the glycosylation
sites to be at the C-terminus as indicated by the black boxes. In agreement with previous
reports that investigated Oglycosylation sites [11, 24], we also found a relatively high
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propensity for Pro and Ala present. Whether this is a result of an enzymatic preference or of
the higher tendency of Pro containing peptides to fragment and thus enable glycopeptide
identification remains to be further studied.
4. Discussion
Using a global glycoproteomics strategy, we have been able to identify novel glycopeptides
in novel mycobacterial glycoproteins. In all cases presented in this study, the confidence that
the modified peptide is a glycopeptide is high as evidenced by the score and the assignment
of the respective ion series. In many cases, glycosylation site identification was possible, but
in some cases, the definite assignment of the glycosylation site(s) remains ambiguous at this
point, particularly when multiple hexoses are attached to one peptide. Possible explanations
for this ambiguity lie in the fragmenting nature of the glycosylation sites and the likely co-
occurrence of isomeric glycopeptides. When the hexose modification fragments more easily
than the backbone peptide, positional information was sometimes lost. This ambiguity was
observed with all fragmentation techniques used, including ETD.
In addition, in many cases, clusters of glycosylations have been observed, where more than
one hexose was present. Apparently, this complicates data interpretation, particularly when
chimeric spectra were observed. Isobaric glycopeptides with positional isomers (e.g. hexose
on S1 or S2) are unlikely to be separated by reversed phase chromatography, thus isobaric
glycopeptides are expected to co-elute. When subjected to dissociation, fragments from the
positional isomers are expected to be detected. In some cases only a minor fragment ion was
observed for an isomeric glycopeptide, in other cases, a fragment was shared by three or
more isomeric candidates. In these cases, the assignment remained ambiguous. It should be
noted that this clustering of multiple hexoses has previously been observed, and could not be
resolved even when recombinantly expressed proteins were investigated [5–8, 10]. A fact
that complicates matters more is the possibility that hexoses can bind to each other in several
positional isomeric forms e.g. 1–2, 1–3 or 1–6 binding) as has been observed by Michell et
al. [10]. This may very well add additional complexity to the sugar modifications on Mtb
that would be interesting to study. Presumably enriched proteins are currently still needed
for such a comprehensive analysis. While the identification of novel mycobacterial
glycoproteins has great scientific interest due to their likely biological implication in
pathogen-host recognition events, progress in the field has been slow and definitive
glycosylation sites have only been known for four mycobacterial glycoproteins. This study
triples the number of known glycoproteins, many of which are clearly understudied and only
putative names and functions are assigned. It can be expected that the characterization of
these proteins as glycoproteins will spark further studies in this area.
5. Conclusions
In this study the CID, HCD and ETD fragmentation techniques were used to identify and
characterize O-glycosylation in Mtb with high confidence. We have demonstrated that all
techniques are capable of identifying O-glycosylation sites of so far uncharacterized
mycobacterial glycoproteins. This analysis was focused on simple sugar modifications such
as mannosylations. Sequence logo amino acid distribution analysis showed an enrichment of
hydrophobic Pro and Ala around the glycosylation sites. This study more than tripled the
characterization of glycosylation sites in known mycobacterial proteins.
We envision that these methods could be used for the identification and characterization of
glycosylation sites in other mycobacterial subcellular fractions and be extended to other
organisms.
Smith et al. Page 7
J Proteomics. Author manuscript; available in PMC 2015 January 31.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
The Proteome Exploration Laboratory is funded by the Gordon and Betty Moore Foundation through Grant
GBMF775, the Beckman Institute and +the NIH award SRR029594A.
REFERENCES
1. Organization WH. Global Tuberculosis Report. 2012. ISBN 978 92 4 156450 2
2. Torrelles JB, Schlesinger LS. Diversity in Mycobacterium tuberculosis mannosylated cel lwall
determinants impacts adaptation to the host. Tuberculosis (Edinb). 2010; 90:84–93. [PubMed:
20199890]
3. Graham RLJ, Hess S. Mass Spectrometry in the Elucidation of the Glycoproteome of Bacterial
Pathogens. Curr Proteomics. 2010; 7:57–81.
4. Espitia C, Mancilla R. Identification, isolation and partial characterization of Mycobacterium
tuberculosis glycoprotein antigens. Clin Exp Immunol. 1989; 77:378–383. [PubMed: 2478323]
5. Dobos KM, Khoo KH, Swiderek KM, Brennan PJ, Belisle JT. Definition of the full extent of
glycosylation of the 45-kilodalton glycoprotein of Mycobacterium tuberculosis. Journal of
Bacteriology. 1996; 178:2498–2506. [PubMed: 8626314]
6. Dobos KM, Swiderek K, Khoo KH, Brennan PJ, Belisle JT. Evidence for glycosylation sites on the
45-kilodalton glycoprotein of Mycobacterium tuberculosis. Infection and Immunity. 1995;
63:2846–2853. [PubMed: 7622204]
7. Horn C, Namane A, Pescher P, Riviere M, Romain F, Puzo G, et al. Decreased capacity of
recombinant 45/47-kDa molecules (Apa) of Mycobacterium tuberculosis to stimulate T lymphocyte
responses related to changes in their mannosylation pattern. The Journal of Biological Chemistry.
1999; 274:32023–32030. [PubMed: 10542234]
8. Sartain MJ, Belisle JT. N-Terminal clustering of the O-glycosylation sites in the Mycobacterium
tuberculosis lipoprotein SodC. Glycobiology. 2009; 19:38–51. [PubMed: 18842962]
9. Herrmann JL, O'Gaora P, Gallagher A, Thole JE, Young DB. Bacterial glycoproteins: a link
between glycosylation and proteolytic cleavage of a 19 kDa antigen from Mycobacterium
tuberculosis. EMBO J. 1996; 15:3547–3554. [PubMed: 8670858]
10. Michell SL, Whelan AO, Wheeler PR, Panico M, Easton RL, Etienne AT, et al. The MPB83
antigen from Mycobacterium bovis contains O-linked mannose and (1-->3)-mannobiose moieties.
The Journal of Biological Chemistry. 2003; 278:16423–16432. [PubMed: 12517764]
11. Herrmann JL, Delahay R, Gallagher A, Robertson B, Young D. Analysis of post-translational
modification of mycobacterial proteins using a cassette expression system. FEBS Lett. 2000;
473:358–362. [PubMed: 10818240]
12. Bell C, Smith GT, Sweredoski MJ, Hess S. Characterization of the Mycobacterium tuberculosis
proteome by liquid chromatography mass spectrometry-based proteomics techniques: a
comprehensive resource for tuberculosis research. Journal of Proteome Research. 2012; 11:119–
130. [PubMed: 22053987]
13. Espitia C, Servin-Gonzalez L, Mancilla R. New insights into protein O-mannosylation in
actinomycetes. Molecular BioSystems. 2010; 6:775–781. [PubMed: 20567761]
14. Gonzalez-Zamorano M, Mendoza-Hernandez G, Xolalpa W, Parada C, Vallecillo AJ, Bigi F, et al.
Mycobacterium tuberculosis glycoproteomics based on ConA-lectin affinity capture of
mannosylated proteins. Journal of Proteome Research. 2009; 8:721–733. [PubMed: 19196185]
15. Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range
mass accuracies and proteome-wide protein quantification. Nature Biotechnology. 2008; 26:1367–
1372.
Smith et al. Page 8
J Proteomics. Author manuscript; available in PMC 2015 January 31.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
16. Cox J, Matic I, Hilger M, Nagaraj N, Selbach M, Olsen JV, et al. A practical guide to the
MaxQuant computational platform for SILAC-based quantitative proteomics. Nature Protocols.
2009; 4:698–705.
17. Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, Mann M. Andromeda: a peptide
search engine integrated into the MaxQuant environment. Journal of Proteome Research. 2011;
10:1794–1805. [PubMed: 21254760]
18. Crooks GE, Hon G, Chandonia JM, Brenner SE. WebLogo: a sequence logo generator. Genome
Research. 2004; 14:1188–1190. [PubMed: 15173120]
19. Abraham EP, Chain E. An enzyme from bacteria able to destroy penicillin. Nature. 1940; 146:837.
20. Milani CJ, Aziz RK, Locke JB, Dahesh S, Nizet V, Buchanan JT. The novel polysaccharide
deacetylase homologue Pdi contributes to virulence of the aquatic pathogen Streptococcus iniae.
Microbiology. 2010; 156:543–554. [PubMed: 19762441]
21. Villen J, Beausoleil SA, Gygi SP. Evaluation of the utility of neutral-loss-dependent MS3
strategies in large-scale phosphorylation analysis. Proteomics. 2008; 8:4444–4452. [PubMed:
18972524]
21. Hahne H, Gholami AM, Kuster B. Discovery of O-GlcNAc-modified Proteins in Published Large-
scale Proteome Data. Molecular & Cellular Proteomics. 2012; 11:843–850. [PubMed: 22661428]
23. Zhao P, Viner R, Teo CF, Boons GJ, Horn D, Wells L. Combining high-energy C-trap dissociation
and electron transfer dissociation for protein O-GlcNAc modification site assignment. Journal of
Proteome Research. 2011; 10:4088–4104. [PubMed: 21740066]
24. Darula Z, Sherman J, Medzihradszky KF. How to dig deeper? Improved enrichment methods for
mucin core-1 type glycopeptides. Molecular & Cellular Proteomics: MCP. 2012; 11 O111 016774.
25. Mikesh LM, Ueberheide B, Chi A, Coon JJ, Syka JE, Shabanowitz J, et al. The utility of ETD
mass spectrometry in proteomic analysis. Biochimica et Biophysica Acta. 2006; 1764:1811–1822.
[PubMed: 17118725]
Smith et al. Page 9
J Proteomics. Author manuscript; available in PMC 2015 January 31.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Highlights
► Glycosylsation sites in Mtb were identified using CID, HCD and ETD
► CID spectra were able to assign glycosylated peptide due to the competition
between backbone and sugar fragmentation
► Thirteen glycoproteins have been identified with high confidence
► Glycosylation sites often cluster and seem to be rich in Pro and Ala
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Figure 1.
Workflow diagram of the strategy to identify O-linked glycopeptide and glycoproteins in
Mtb.
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Figure 2.
CID spectrum of tryptic peptide LNLPPIPLQLPT*PR (aa 362–375) of the uncharacterized
membrane protein Rv3835 indicates monohexosylation at Thr373. Fragment ions that
contain the hexose residue are highlighted in gray.
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Figure 3.
NL MS3 spectrum of tryptic peptide TPPATVPSSR (aa 47–56) of the gamma-
glutamyltransferase indicates a total of six hexoses. The spectrum is dominated by doubly
and singly charged NL ions. Due to the complexity of the fragmentation pattern and possible
combinations, a definite glycosite assignment cannot be made. For instance, the y3 ion was
observed with four Hex indicating four Hex at SSR. Since the y2 ion was not observed, the
possibility remains that either one or both Ser are modified. Fragment ions that contain the
hexose residue are highlighted in gray.
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Figure 4.
HCD spectrum of tryptic peptide QPFSLQLIGPPPS*PVQR (aa 68–83) of the probable
membrane protein Rv2799, previously identified as a glycoprotein candidate [14]. The
monohexose could clearly be located at Ser79. Fragment ions that contain the hexose
residue are highlighted in gray.
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Figure 5.
ETD spectrum of tryptic peptide DIPASEIPPLPNT*S*S*PK (aa 254–270) of the possible
glycosyl hydrolase. Three monohexoses could clearly be located at Thr266, Ser267, Ser268.
Fragment ions that contain the hexose residues are highlighted in gray.
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Figure 6.
The O-glycosylation motif generated from the high confidence identifications indicates a
higher likelihood of hydrophobic Pro and Ala, interspersed with some hydrophilic Thr
around the O-glycosylation site. In addition, the glycosylation motifs seem to cluster at the
C-terminus as indicated by the black boxes on the right.
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